ViaCyte proposes stem cell implant to address type 1 diabetes

05/31/2011 | Los Angeles Times (tiered subscription model)

San Diego-based ViaCyte has proposed implanting a pouch filled with pancreatic cells under the skin to help reduce insulin dependence among patients with type 1 diabetes. The firm tested the procedure to treat diabetes in mice and hopes to initiate human trials in patients by 2013.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN